New Department Chair for Neurology
 |
David Fink
Photo: Marcia Ledford
|
The U-M Medical School has chosen David Fink, M.D., a clinical neurologist
and gene therapy expert, to be the new chair of its Department of Neurology
and the first Robert Brear Professor of Neurology.
Fink is a clinical neurologist whose research focuses on developing gene therapies
for diseases of the nervous system. He comes to U-M from the University of
Pittsburgh where he was a professor of neurology, vice chair for VA affairs
in the Department of Neurology, chief of the neurology service at the VA Pittsburgh
Healthcare System, and director of the system's Geriatric Research Education
and Clinical Center.
"Gene therapy is one of medicine's most exciting new frontiers. David Fink's
expertise in this area will help strengthen U-M's reputation as a leader in
the development of therapeutic technologies in this promising field," says
Allen S. Lichter (M.D. 1972), dean of the U-M Medical School. "David's rare
combination of research excellence, clinical skill and leadership ability will
be invaluable to the U-M Medical School and its neurology department as we
continue to expand programs in research and patient care."
Fink received his M.D. from Harvard Medical School. He completed his residency
in internal medicine at the Massachusetts General Hospital in Boston, was a
postdoctoral research fellow in neurochemistry at the National Institutes of
Health, and served as resident and chief resident in neurology at the University
of California, San Francisco. He is board certified in internal medicine and
neurology.
-SFP
ALSO:
Gil Omenn to Serve as President of the American Association for the Advancement of Science
New Department Chair for Neurology
|
